Gene · 8301
Papers2,227
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 2,227
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transport of Alzheimer's associated amyloid-β catalyzed by P-glycoprotein. | PLoS One | 2021 | 33901197 | PubTator, text mining | PubMed |
| BRD4 PROTAC degrader ARV-825 inhibits T-cell acute lymphoblastic leukemia by targeting 'Undruggable' Myc-pathway genes. | Cancer Cell Int | 2021 | 33888130 | PubTator, text mining | PubMed |
| Beyond association: successes and challenges in linking non-coding genetic variation to functional consequences that modulate Alzheimer's disease risk. | Mol Neurodegener | 2021 | 33882988 | PubTator, text mining | PubMed |
| The role of nanotechnology in current COVID-19 outbreak. | Heliyon | 2021 | 33880422 | PubTator, text mining | PubMed |
| Transcriptomic analysis to identify genes associated with selective hippocampal vulnerability in Alzheimer's disease. | Nat Commun | 2021 | 33875655 | PubTator, text mining | PubMed |
| Emerging Biomarkers for Predicting Bladder Cancer Lymph Node Metastasis. | Front Oncol | 2021 | 33869048 | PubTator, text mining | PubMed |
| Novel Cell-Penetrating Peptides Derived From Scaffold-Attachment- Factor A Inhibits Cancer Cell Proliferation and Survival. | Front Oncol | 2021 | 33859938 | PubTator, text mining | PubMed |
| Emerging genetic complexity and rare genetic variants in neurodegenerative brain diseases. | Genome Med | 2021 | 33853652 | PubTator, text mining | PubMed |
| Multiomics integrative analysis identifies APOE allele-specific blood biomarkers associated to Alzheimer's disease etiopathogenesis. | Aging (Albany NY) | 2021 | 33846280 | PubTator, text mining | PubMed |
| Phosphoinositides: Roles in the Development of Microglial-Mediated Neuroinflammation and Neurodegeneration. | Front Cell Neurosci | 2021 | 33841102 | PubTator, text mining | PubMed |
| Focused role of nanoparticles against COVID-19: Diagnosis and treatment. | Photodiagnosis Photodyn Ther | 2021 | 33836276 | PubTator, text mining | PubMed |
| An extended catalogue of tandem alternative splice sites in human tissue transcriptomes. | PLoS Comput Biol | 2021 | 33826604 | PubTator, text mining | PubMed |
| The Function of Selenium in Central Nervous System: Lessons from MsrB1 Knockout Mouse Models. | Molecules | 2021 | 33806413 | PubTator, text mining | PubMed |
| An Analysis of the Neurological and Molecular Alterations Underlying the Pathogenesis of Alzheimer's Disease. | Cells | 2021 | 33806317 | PubTator, text mining | PubMed |
| Chasing the Target: New Phenomena of Resistance to Novel Selective RET Inhibitors in Lung Cancer. Updated Evidence and Future Perspectives. | Cancers (Basel) | 2021 | 33806299 | PubTator, text mining | PubMed |
| Whole-genome sequencing reveals new Alzheimer's disease-associated rare variants in loci related to synaptic function and neuronal development. | Alzheimers Dement | 2021 | 33797837 | PubTator, text mining | PubMed |
| Revisiting the Relationship Between Alzheimer's Disease and Cancer With a circRNA Perspective. | Front Cell Dev Biol | 2021 | 33777952 | PubTator, text mining | PubMed |
| Successful treatment of T/myeloid mixed-phenotype acute leukemia with the translocation (10;11)(p13;q14) PICALM/AF10 with 3 + 7 myeloid standard treatment: A case report. | Clin Case Rep | 2021 | 33768878 | PubTator, text mining | PubMed |
| Nanotechnology advances in pathogen- and host-targeted antiviral delivery: multipronged therapeutic intervention for pandemic control. | Drug Deliv Transl Res | 2021 | 33748879 | PubTator, text mining | PubMed |
| APOE-ε4 Carrier Status and Gut Microbiota Dysbiosis in Patients With Alzheimer Disease. | Front Neurosci | 2021 | 33732104 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8301/papers?page=36